Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease.
Τίτλος | Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Polyzos, S. A., Goulis D. G., Giouleme O., Germanidis G. S., & Goulas A. |
Journal | Curr Obes Rep |
Date Published | 2022 May 02 |
ISSN | 2162-4968 |
Abstract | PURPOSE OF REVIEW: Obesity is closely associated with nonalcoholic fatty liver disease (NAFLD), a highly prevalent disease without any approved medication. The aim of this review was to summarize the evidence on the effect of anti-obesity medications on NAFLD, especially focusing on hepatic histology. |
DOI | 10.1007/s13679-022-00474-0 |
Alternate Journal | Curr Obes Rep |
PubMed ID | 35501557 |